Sodium stearate structure
|
Common Name | Sodium stearate | ||
|---|---|---|---|---|
| CAS Number | 822-16-2 | Molecular Weight | 306.459 | |
| Density | 1.103 g/cm3 | Boiling Point | 359.4ºC at 760 mmHg | |
| Molecular Formula | C18H35NaO2 | Melting Point | 245 - 255ºC | |
| MSDS | Chinese USA | Flash Point | 162.4ºC | |
Use of Sodium stearateSodium stearate is a biochemical reagent that can be used as a biological material or organic compound for life science related research. |
| Name | Sodium stearate |
|---|---|
| Synonym | More Synonyms |
| Description | Sodium stearate is a biochemical reagent that can be used as a biological material or organic compound for life science related research. |
|---|---|
| Related Catalog |
| Density | 1.103 g/cm3 |
|---|---|
| Boiling Point | 359.4ºC at 760 mmHg |
| Melting Point | 245 - 255ºC |
| Molecular Formula | C18H35NaO2 |
| Molecular Weight | 306.459 |
| Flash Point | 162.4ºC |
| Exact Mass | 306.253479 |
| PSA | 40.13000 |
| LogP | 4.99780 |
| Storage condition | 2-8°C |
| Stability | Stable. Incompatible with strong oxidizing agents. |
| Water Solubility | SOLUBLE IN COLD AND HOT WATER |
CHEMICAL IDENTIFICATION
HEALTH HAZARD DATAACUTE TOXICITY DATA
|
|
~%
Detail
|
| Literature: US2006/30725 A1, ; Page/Page column 6 ; |
|
~%
Sodium stearate CAS#:822-16-2 |
| Literature: Zeitschrift fuer Physikalische Chemie (Leipzig), , vol. 262, # 6 p. 1009 - 1031 |
| Precursor 5 | |
|---|---|
| DownStream 10 | |
| HS Code | 2915709000 |
|---|---|
| Summary | 2915709000. palmitic acid and its salts and esters. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:5.5%. General tariff:30.0% |
|
Solid lipid nanoparticles for potential doxorubicin delivery in glioblastoma treatment: preliminary in vitro studies.
J. Pharm. Sci. 103(7) , 2157-65, (2014) The major obstacle to glioblastoma pharmacological therapy is the overcoming of the blood-brain barrier (BBB). In literature, several strategies have been proposed to overcome the BBB: in this experim... |
|
|
Kinetically stable propofol emulsions with reduced free drug concentration for intravenous delivery.
Int. J. Pharm. 486 , 232-41, (2015) Intravenous injections of propofol emulsions are accompanied by pain likely due to the interaction of the dissolved drug with endothelial cells of the vasculature. It is commonly hypothesized that red... |
|
|
A drug formulation using an alginate hydrogel matrix for efficient oral delivery of the manganese porphyrin-based superoxide dismutase mimic.
Biomater. Sci. 3 , 861-9, (2015) In order for patients to avail of the therapeutic benefits of antioxidant drugs efficiently and conveniently, a robust oral delivery system needs to be developed. However, a common problem in oral dru... |
| sodium,octadecanoate |
| Octadecanoic acid, sodium salt (1:1) |
| Octadecanoic acid sodium salt |
| octadecanoic acid, sodium salt |
| Sodium stearate |
| SODIUM OCTADECANOATE |
| EINECS 212-490-5 |
| Stearic Acid, Sodium Salt |
| stearic acid sodium salt |
| MFCD00036404 |